Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
Clinical trial NCT03274973 · TERMINATED
Trial details
- NCT number
- NCT03274973
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-14
- Primary completion
- 2018-10-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.